Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
213M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
82.3M
-
Shares change
-
+457K
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
-$9.3M
-
Put/Call ratio
-
5.03
-
Number of buys
-
61
-
Number of sells
-
-52
-
Price
-
$13.12
Significant Holders of INSMED Inc - Common stock, par value $0.01 per share (INSM) as of Q4 2018
159 filings reported holding INSM - INSMED Inc - Common stock, par value $0.01 per share as of Q4 2018.
INSMED Inc - Common stock, par value $0.01 per share (INSM) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.3M shares
of 213M outstanding shares and own 38.64% of the company stock.
Largest 10 shareholders include FMR LLC (11.6M shares), JANUS HENDERSON GROUP PLC (11.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.68M shares), Palo Alto Investors LP (7.65M shares), BlackRock Inc. (7.45M shares), Vanguard Group Inc (6.95M shares), STATE STREET CORP (3.31M shares), Foresite Capital Management IV, LLC (1.98M shares), BAKER BROS. ADVISORS LP (1.85M shares), and Voya Investment Management LLC (1.27M shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.